V. Randy White
Geen lopende functies
Profiel
V.
Randy White served as Chief Executive Officer at Cardiff Oncology, Inc. from 2004 to 2006.
He also served as Chief Executive Officer at Adnavance Technologies, Inc. and as Laboratory Director at Laboratory Corporation of America, Inc. Additionally, he was President at Ngen, Inc. and Executive Vice President-Operations at Quest Diagnostics Nichols Institute, Inc.
Eerdere bekende functies van V. Randy White
Bedrijven | Functie | Einde |
---|---|---|
CARDIFF ONCOLOGY, INC. | President | 01-03-2006 |
NGEN INC | President | - |
Quest Diagnostics Nichols Institute, Inc.
Quest Diagnostics Nichols Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Quest Diagnostics, Inc., Quest Diagnostics Nichols Institute, Inc. is a medical laboratory company. The company is based in Chantilly, VA. Quest Diagnostics Nichols Institute was acquired by Quest Diagnostics, Inc. from GTCR LLC on April 01, 2002 for $500 million. | Operationeel Directeur | - |
Laboratory Corporation of America, Inc.
Laboratory Corporation of America, Inc. Medical/Nursing ServicesHealth Services Part of Laboratory Corp. of America Holdings, Laboratory Corporation of America, Inc. provides clinical laboratory services. The company is based in Beardstown, IL. | Corporate Officer/Principal | - |
Adnavance Technologies, Inc.
Adnavance Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Adnavance is a molecular diagnostic company focused on development of DNA-based tests using the Company's patented metalized DNA (M-DNA) platform. The Company is headquartered in Vancouver, British Columbia and also maintains a DNA development laboratory in San Diego, CA. M-DNA is based on the conducting properties of hybridized DNA. Under strict reaction conditions, certain metal ions can enter the central core of hybridized DNA and displace the hydrogen bonds forming the equivalent of a metal wire in the center of the DNA and making the DNA highly conductive. The Company uses a microarray of 10-micron electrodes to detect the M-DNA and the inherent ultra-sensitivity arises from the differential change in conductivity between hybridized DNA and metalized DNA. This change in conductivity is so large that it obviates the need for target amplification used in current molecular-based tests. Adnavance scientists were the first to discover the M-DNA phenomenon, and the Company believes its technology platform will open new molecular testing markets. | Algemeen Directeur | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
CARDIFF ONCOLOGY, INC. | Health Technology |
Bedrijven in privébezit | 4 |
---|---|
Adnavance Technologies, Inc.
Adnavance Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Adnavance is a molecular diagnostic company focused on development of DNA-based tests using the Company's patented metalized DNA (M-DNA) platform. The Company is headquartered in Vancouver, British Columbia and also maintains a DNA development laboratory in San Diego, CA. M-DNA is based on the conducting properties of hybridized DNA. Under strict reaction conditions, certain metal ions can enter the central core of hybridized DNA and displace the hydrogen bonds forming the equivalent of a metal wire in the center of the DNA and making the DNA highly conductive. The Company uses a microarray of 10-micron electrodes to detect the M-DNA and the inherent ultra-sensitivity arises from the differential change in conductivity between hybridized DNA and metalized DNA. This change in conductivity is so large that it obviates the need for target amplification used in current molecular-based tests. Adnavance scientists were the first to discover the M-DNA phenomenon, and the Company believes its technology platform will open new molecular testing markets. | Commercial Services |
Laboratory Corporation of America, Inc.
Laboratory Corporation of America, Inc. Medical/Nursing ServicesHealth Services Part of Laboratory Corp. of America Holdings, Laboratory Corporation of America, Inc. provides clinical laboratory services. The company is based in Beardstown, IL. | Health Services |
Quest Diagnostics Nichols Institute, Inc.
Quest Diagnostics Nichols Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Quest Diagnostics, Inc., Quest Diagnostics Nichols Institute, Inc. is a medical laboratory company. The company is based in Chantilly, VA. Quest Diagnostics Nichols Institute was acquired by Quest Diagnostics, Inc. from GTCR LLC on April 01, 2002 for $500 million. | Commercial Services |
Ngen, Inc.
Ngen, Inc. Medical SpecialtiesHealth Technology Ngen, Inc. advanced diagnostics provides physicians and patients worldwide with sophisticated information to predict, diagnose and treat disease. Research and clinical reference labs use the highly accurate and reliable NanoChip(R) Molecular Biology Workstation, NanoChip(R) Electronic Microarray and broad suite of analyte specific reagents to develop diagnostic tests for variety of diseases. Nanogen also offers a broad portfolio of patented nucleic acids chemistries and molecular tools that accelerate genomic analysis and are compatible with many systems. The SynX subsidiary offers a line of point-of-care diagnostic tests and is building expertise in cardiac related health conditions. Nanogen's ten years of pioneering research involving nanotechnology may also have future applications in medical diagnostics, biowarfare and other industries. The company is headquartered in San Diego, CA | Health Technology |